Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Lam Research (LRCX, NASDAQ): To the Insiders -- Ignore unavailable to you. Want to Upgrade?

To: etchmeister who wrote (5368)	7/22/2005 12:05:05 PM
From: All Mtn Ski	Respond to of 5867

You are exactly right, mastering the art of IC manufacturing with higher yields and lower costs than your competitors is how you win, IMHO. A-M-S

To: etchmeister who wrote (5368)	8/25/2005 11:07:03 AM
From: Proud_Infidel	Respond to of 5867

Lam Research Upbeat On Memory-Order Rebound David Ng, 08.25.05, 10:58 AM ET Adams Harkness reiterated a "market perform" rating on Lam Research (nasdaq: LRCX - news - people ), saying the company's planned share buyback is a near-term positive. Lam announced its board has authorized a $500 million share-buyback plan. Under the program, shares may be purchased through September 2008. "We believe a large share-buyback plan such as this shows management's confidence in the cash-generation capability of the company," Adams Harkness said. The research firm added that Lam is upbeat about the calendar fourth quarter as memory orders are starting to come back. "We point that Lam has a higher-than-average exposure to memory, and as a result of a slowdown at the memory makers, the company had guided for orders to be flat to down 5% quarter-over-quarter in the calendar third quarter," the research firm said. Adams Harkness said positive commentary from industry bellwether Applied Materials (nasdaq: AMAT - news - people ) and the announcement from Lam are near-term positives for the semiconductor-equipment group.